Those above the age of three years will be given the QMMV (Quadrivalent Meningococcal Meningitis Vaccine) and those above 65 will also be g...

The vaccine, a mist that is sucked in through the mouth, is being offered for free as a booster dose for previously vaccinated individuals,...

Vaxart had started trials of its oral recombinant tablet vaccine in October last year. It enrolled 96 participants at four centres in the U...

Now, in a surprising twist in the decades-long effort to eradicate the virus, authorities in Jerusalem, New York and London have discovered...

Pfizer Inc Chief Executive Officer Albert Bourla said he had started a course of the company's oral COVID-19 antiviral treatment, Paxlovid,...

The research, published in the journal Science Translational Medicine, demonstrates the potential of the vaccine to work through the mucosa...

South Africa has been struggling with its plans to achieve the herd immunity through vaccinations, with widespread vaccine hesitancy, large...

The antiviral medications stop the virus from replicating in the body.

One promising drug that could improve things is molnupiravir, an antiviral that's moving into the final stages of testing in humans. Resear...

The proposed research project will be done in collaboration with a German firm and it has been shortlisted for presentation.

District treasury officer and other departmental heads have been given directions to implement the order and were asked to make a list and ...

The Kerala High Court on Friday sought a timeframe from the Centre within which the southern state is likely to get the COVID-19 vaccines. ...

The drugmaker, which developed the first authorized COVID-19 vaccine in the U.S. with Germany's BioNTech SA, said the antiviral candidate s...

"Today, in spite of the fact that virtually all the countries in the world have eradicated polio, two of our neighbouring countries still h...

After closer review of the data related to allergic reactions, the US FDA recommended that the mRNA vaccines, based on the genetic material...

Anyone who had a severe reaction to a COVID-19 vaccine should not get the second dose, the agency said, defining severe as needing the medi...

It also announced a partnership with privately-held Ridgeback Biotherapeutics to develop an experimental oral antiviral drug against COVID-...